InnoSIGN

About InnoSIGN

InnoSIGN is a biotech company that takes a biology-first approach to analyzing the relationships and interactions between signaling pathways to discern a series of disease driver events. Our proprietary platform quantifies the activity of 10+ essential disease-driving pathways by leveraging our proprietary structured ML algorithms developed over 10 years of research at Philips. We enable our partners to gain more insights and accelerate their discoveries and innovations.

Keywords

• Biotech
• Diagnostics
• Genomics
• Molecular Diagnostics
• Oncology
• Oncosignal
• Precision Medicine
• Signaling Pathways

Address

• Headquarters

  High Tech Campus 115656AE EindhovenNoord-Brabant, Netherlands

Team by function

Based on 2 public job profiles as of 3 September 2026.

• Executive / C-Suite1
• Product Management1